Nic G. Scalfarotto
Keine laufenden Positionen mehr
Karriereverlauf von Nic G. Scalfarotto
Ehemalige bekannte Positionen von Nic G. Scalfarotto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KURA ONCOLOGY, INC. | General Counsel | - | - |
X4 PHARMACEUTICALS, INC. | General Counsel | 01.11.2018 | - |
AEGERION PHARMACEUTICALS, INC. | General Counsel | 01.06.2017 | - |
MOMENTA PHARMACEUTICALS, INC. | General Counsel | 16.05.2011 | - |
Ausbildung von Nic G. Scalfarotto
Seton Hall University | Undergraduate Degree |
Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Italien | 2 |
Operativ
General Counsel | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
KURA ONCOLOGY, INC. | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Nic G. Scalfarotto
- Erfahrung